Product-Line Extensions and Pricing Strategies of Brand-Name Drugs Facing Patent Expiration

OBJECTIVES: This study proposed an alternative to brand loyalty as the explanation for the continued price rigidity of patent-expired brand-name prescription drugs despite the increase in market entry of generic drugs facilitated by the 1984 Drug Price Competition and Patent Term Restoration Act. St...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Song Hee, Shepherd, Marvin D., Scoones, David, Wan, Thomas T.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2005
Materias:
Formulary Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437316/
https://www.ncbi.nlm.nih.gov/pubmed/16300418
http://dx.doi.org/10.18553/jmcp.2005.11.9.746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437316/
https://www.ncbi.nlm.nih.gov/pubmed/16300418
http://dx.doi.org/10.18553/jmcp.2005.11.9.746

Ejemplares similares